Quarterly report pursuant to Section 13 or 15(d)

Note Payable - Additional Information (Detail)

v3.7.0.1
Note Payable - Additional Information (Detail)
3 Months Ended 9 Months Ended 12 Months Ended
May 20, 2016
USD ($)
Apr. 22, 2016
USD ($)
Jun. 30, 2015
USD ($)
Installments
Feb. 28, 2017
USD ($)
Feb. 29, 2016
USD ($)
Mar. 31, 2016
USD ($)
Nov. 30, 2016
USD ($)
Aug. 26, 2016
USD ($)
Jul. 01, 2016
USD ($)
Debt Instrument [Line Items]                  
Note payable       $ 7,353,903     $ 7,819,750    
Debt instrument payment       500,000 $ 75,423        
Gain on extinguishment of debt             300,593    
Notes payable, interest expense       121,988 0        
Interest expense       297,044 261,334        
Debt issuance costs       378,785          
Amortization of debt issuance costs       34,153 0        
Texas Capital Bank National Association [Member] | Amended And Restated Promissory Notes [Member]                  
Debt Instrument [Line Items]                  
Principal paid       1,133,000     $ 633,000    
Interest expense       $ 102,488 0        
TCB and CrowdOut Capital LLC [Member]                  
Debt Instrument [Line Items]                  
Subordinated loan $ 650,000                
TCB and CrowdOut Capital LLC [Member] | Subordinated Debt [Member]                  
Debt Instrument [Line Items]                  
Line of credit facility, interest rate 12.00%                
Line of credit facility, expiration date Jul. 31, 2021                
Line of credit facility, description       Per a promissory note dated May 20, 2016 between the Company and CrowdOut, interest at 12% per annum on the principal sum of $650,000 is payable monthly with a maturity date of July 2021, at which time, the principal amount of $650,000 is payable.          
Line of credit facility, frequency of payment       Monthly          
Interest expense       $ 19,500 0        
Notes Payable [Member]                  
Debt Instrument [Line Items]                  
Asset purchase agreement commencement date     Jul. 31, 2015            
Asset purchase agreement closing date     Jun. 30, 2019            
Notes payable, interest expense         $ 14,391        
Senior Credit Facilities [Member] | Texas Capital Bank National Association [Member] | Term Loan [Member]                  
Debt Instrument [Line Items]                  
Line of credit facility, description       Subject to the terms of the Agreement, on May 20, 2016, TCB advanced the Company $100.00. On July 1, 2016, TCB advanced the remaining principal amount of $7,999,900 per a promissory note dated May 20, 2016 between the Company and TCB, at a rate of 3.75% per annum plus LIBOR, payable monthly with a maturity date of July 2021.          
Line of credit facility, frequency of payment       Monthly          
Line of credit facility, interest rate description       3.75% per annum plus LIBOR          
Senior Credit Facilities [Member] | Texas Capital Bank National Association [Member] | Promissory Notes [Member] | Term Loan [Member]                  
Debt Instrument [Line Items]                  
Line of credit facility, amount advanced                 $ 7,999,900
Senior Credit Facilities [Member] | London Interbank Offered Rate (LIBOR) [Member] | Texas Capital Bank National Association [Member] | Term Loan [Member]                  
Debt Instrument [Line Items]                  
Term loan, maximum borrowing capacity $ 8,000,000                
Line of credit facility, amount advanced $ 100.00                
Line of credit facility, interest rate 3.75%     3.75%     3.75%    
Line of credit facility, expiration date Jul. 31, 2021                
Amended Senior Credit Facility [Member] | Texas Capital Bank National Association [Member] | Amended And Restated Promissory Notes [Member] | Term Loan [Member]                  
Debt Instrument [Line Items]                  
Line of credit facility, amount advanced               $ 2,133,433  
Asset Purchase Agreement [Member]                  
Debt Instrument [Line Items]                  
Note payable     $ 1,300,000            
Asset Purchase Agreement [Member] | CytoMedical [Member]                  
Debt Instrument [Line Items]                  
Debt instrument payment   $ 778,287       $ 269,443      
Asset Purchase Agreement [Member] | Notes Payable [Member]                  
Debt Instrument [Line Items]                  
Number of monthly installments | Installments     48            
Repayment interval       Monthly          
Monthly installment amount     $ 29,938            
Annual interest rate     5.00%